| US 7,582,439 B2 | ||
| Therapeutic molecules | ||
| Suzanne Cory, North Melbourne (Australia); Jerry Adams, North Melbourne (Australia); David C. S. Huang, Carlton (Australia); Liam O'Connor, Coburg (Australia); Andreas Strasser, Ascot Vale (Australia); Hamsa Puthalakath, East Keilor (Australia); and Lorraine O'Reilly, Cheltenham (Australia) | ||
| Assigned to The Walter and Eliza Hall Institute of Medical Research, Parkville Victoria (Australia) | ||
| Filed on Apr. 24, 2006, as Appl. No. 11/409,944. | ||
| Application 11/409944 is a division of application No. 09/508832, granted, now 7,064,193, previously published as PCT/AU98/00772, filed on Sep. 17, 1998. | ||
| Claims priority of application No. PO9263 (AU), filed on Sep. 17, 1997; and application No. PO9373 (AU), filed on Sep. 24, 1997. | ||
| Prior Publication US 2006/0183687 A1, Aug. 17, 2006 | ||
| Int. Cl. G01N 33/536 (2006.01) | ||
| U.S. Cl. 435—7.1 [436/536; 436/518] | 18 Claims |
| 1. A method for detecting a Bim molecule encoded by the human Bim gene on human chromosome 2 at bands 2q 12-2q 13 or the mouse
Bim gene on chromosome 2 at bands F3-G in a biological sample comprising:
providing a biological sample from a subject that contains a Bim molecule;
contacting said biological sample that contains said Bim molecule with an antibody specific for SEQ ID NO: 10 under conditions
sufficient to bind said Bim molecule; and
detecting the presence or absence of a complex comprising said a Bim molecule and said antibody.
|